HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wei Hu Selected Research

Aryl Hydrocarbon Receptor Nuclear Translocator

6/2022Retraction: Downregulated brain and muscle aryl hydrocarbon receptor nuclear translocator-like protein-1 inhibits osteogenesis of BMSCs through p53 in type 2 diabetes mellitus.
10/2020Expression of Concern: Downregulated brain and muscle aryl hydrocarbon receptor nuclear translocator-like protein-1 inhibits osteogenesis of BMSCs through p53 in type 2 diabetes mellitus.
1/2020Downregulated brain and muscle aryl hydrocarbon receptor nuclear translocator-like protein-1 inhibits osteogenesis of BMSCs through p53 in type 2 diabetes mellitus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wei Hu Research Topics

Disease

232Neoplasms (Cancer)
12/2022 - 03/2002
68Inflammation (Inflammations)
12/2022 - 07/2006
65Infections
03/2022 - 01/2003
48Ovarian Neoplasms (Ovarian Cancer)
10/2022 - 03/2002
48Lung Neoplasms (Lung Cancer)
10/2022 - 01/2009
28Carcinogenesis
01/2022 - 01/2005
27Neoplasm Metastasis (Metastasis)
01/2022 - 01/2002
27Hepatocellular Carcinoma (Hepatoma)
01/2022 - 04/2010
26Breast Neoplasms (Breast Cancer)
05/2022 - 03/2002
24Fibrosis (Cirrhosis)
02/2020 - 04/2013
23Carcinoma (Carcinomatosis)
01/2022 - 03/2002
16Necrosis
10/2022 - 12/2003
16Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 07/2005
14Hypoxia (Hypoxemia)
01/2022 - 04/2008
14Pain (Aches)
07/2020 - 01/2013
14Schistosomiasis (Bilharziasis)
10/2018 - 01/2003
13Autoimmune Diseases (Autoimmune Disease)
10/2022 - 01/2009
13Reperfusion Injury
05/2022 - 10/2006
13Disease Progression
01/2021 - 04/2011
12Ischemia
01/2022 - 10/2006
12Parkinson Disease (Parkinson's Disease)
01/2021 - 12/2014
12Nasopharyngeal Carcinoma
03/2019 - 12/2009
11Stroke (Strokes)
05/2022 - 11/2005
11COVID-19
04/2022 - 01/2020
11Rheumatoid Arthritis
05/2021 - 03/2011
10Type 2 Diabetes Mellitus (MODY)
06/2022 - 02/2009
10Obesity
06/2022 - 05/2011
10Osteoarthritis
04/2022 - 01/2015
10Insulin Resistance
01/2022 - 08/2009
10Ischemic Stroke
01/2022 - 07/2010
10Prostatic Neoplasms (Prostate Cancer)
08/2021 - 05/2010
10Ovarian Epithelial Carcinoma
01/2019 - 09/2003
9Brain Injuries (Brain Injury)
08/2022 - 01/2013
9Wounds and Injuries (Trauma)
04/2022 - 10/2011
9Stomach Neoplasms (Stomach Cancer)
01/2022 - 10/2012
9Atherosclerosis
11/2021 - 03/2009
9Non-Hodgkin Lymphoma (Lymphosarcoma)
11/2019 - 09/2010
9Liver Cirrhosis (Hepatic Cirrhosis)
04/2017 - 12/2005
8Hypertension (High Blood Pressure)
03/2022 - 08/2008
8Adenocarcinoma of Lung
01/2022 - 04/2012
8Melanoma (Melanoma, Malignant)
01/2022 - 03/2011
8Sepsis (Septicemia)
12/2021 - 11/2006
8Myocardial Infarction
11/2021 - 01/2016
8Myocardial Ischemia (Ischemic Heart Diseases)
11/2021 - 08/2012
8Mitochondrial Diseases (Mitochondrial Disease)
11/2021 - 01/2012
8Cardiovascular Diseases (Cardiovascular Disease)
10/2021 - 01/2016
8Echinococcosis (Hydatid Cysts)
02/2021 - 06/2013
8Malaria
12/2018 - 01/2013
7Atrial Fibrillation
07/2022 - 10/2014
7Body Weight (Weight, Body)
01/2022 - 02/2008

Drug/Important Bio-Agent (IBA)

101Proteins (Proteins, Gene)FDA Link
07/2022 - 01/2002
52Biomarkers (Surrogate Marker)IBA
08/2022 - 12/2005
48Biological ProductsIBA
10/2022 - 03/2002
42Pharmaceutical PreparationsIBA
06/2022 - 03/2002
28CytokinesIBA
10/2022 - 09/2003
27Messenger RNA (mRNA)IBA
01/2022 - 12/2003
25MicroRNAs (MicroRNA)IBA
12/2022 - 01/2012
22AntigensIBA
01/2022 - 01/2008
21Coal (Coals)IBA
12/2021 - 08/2012
20Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2022 - 07/2005
19Long Noncoding RNAIBA
12/2022 - 01/2016
18DNA (Deoxyribonucleic Acid)IBA
03/2019 - 02/2003
17LigandsIBA
12/2022 - 12/2003
17RNA (Ribonucleic Acid)IBA
04/2022 - 06/2006
17EnzymesIBA
01/2022 - 10/2003
16VaccinesIBA
04/2022 - 06/2009
15Small Interfering RNA (siRNA)IBA
07/2020 - 09/2011
14Paclitaxel (Taxol)FDA LinkGeneric
01/2022 - 12/2009
14Therapeutic UsesIBA
01/2021 - 02/2008
14Cisplatin (Platino)FDA LinkGeneric
01/2021 - 07/2004
13PlatinumIBA
01/2022 - 09/2003
12Interleukin-6 (Interleukin 6)IBA
09/2022 - 02/2012
12Glucose (Dextrose)FDA LinkGeneric
06/2022 - 08/2009
12Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 03/2003
12Peptides (Polypeptides)IBA
01/2022 - 09/2003
12MelatoninIBA
12/2021 - 01/2016
12AntibodiesIBA
12/2021 - 01/2003
12C-Reactive ProteinIBA
01/2021 - 08/2008
12CollagenIBA
10/2019 - 12/2005
10Oxygen (Dioxygen)IBA
05/2022 - 11/2006
10LipidsIBA
03/2022 - 08/2008
10AntioxidantsIBA
12/2021 - 04/2007
10fu-yuanIBA
12/2021 - 01/2014
9InflammasomesIBA
04/2022 - 01/2014
8Phosphotransferases (Kinase)IBA
01/2022 - 06/2006
8Circular RNAIBA
11/2021 - 01/2018
8Reactive Oxygen Species (Oxygen Radicals)IBA
07/2021 - 01/2012
8Caspase 3 (Caspase-3)IBA
09/2020 - 07/2004
7InterferonsIBA
03/2022 - 03/2002
7AcidsIBA
03/2022 - 10/2004
7ImmunosorbentsIBA
01/2022 - 10/2003

Therapy/Procedure

119Therapeutics
05/2022 - 03/2002
35Drug Therapy (Chemotherapy)
01/2022 - 01/2003
22Deep Brain Stimulation
10/2021 - 01/2013
15Immunotherapy
01/2022 - 01/2013
15Radiotherapy
01/2022 - 12/2009
9Transplantation
01/2021 - 10/2013
9Aftercare (After-Treatment)
08/2020 - 03/2002
8Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
03/2019 - 05/2010
7Length of Stay
11/2022 - 01/2014